Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
11 Dec 2024
// PHARMAWEB
https://www.pharmiweb.com/press-release/2024-12-11/leriglitazone-has-met-the-primary-endpoint-in-nexus-the-pivotal-trial-for-pediatric-patients-with-cerebral-adrenoleukodystrophy
26 Jan 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/minoryx-clutching-data-failed-trial-knocked-back-ema-vows-seek-rerun-review
01 Jun 2023
// CLINICAL TRIALS ARENA
https://www.clinicaltrialsarena.com/news/fda-minoryx-phase-iii-trial-cald-therapy/
10 Nov 2022
// EUROPEANPHARMACEUTICALREVIEW
https://www.europeanpharmaceuticalreview.com/news/176282/minoryx-and-neuraxpharm-therapy-for-rare-cns-disorders/
20 Sep 2022
// PHARMIWEB
https://www.pharmiweb.com/press-release/2022-09-20/minoryx-s-marketing-authorization-application-for-its-lead-candidate-leriglitazone-validated-by-ema-for-orphan-indication-x-linked-adrenoleukodystrophy-x-ald
31 May 2022
// Nick Paul Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/bouncing-back-late-phase-fail-minoryx-pockets-eu51m-guide-rare-disease-drug-market
ABOUT THIS PAGE